PharMerica (PMC) Reports Q3 Adj-EPS of 21c; Narrows FY10 Outlook
Tweet Send to a Friend
PharMerica (NYSE: PMC) reports Q3 EPS of $0.21, ex-items ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
